BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report

Three-part report investigates rapid pipeline growth, partnerships, clinical trials , and patient access challenges in cancer treatment
LONDON , April 30, 2024 /CNW/ -- BioWorld published by Clarivate Plc (NYSE:CLVT), a leading global pro
Read more...